Nintedanib, sold under the brand names Ofev and Vargatef, is an oral medication used for the treatment of idiopathic pulmonary fibrosis and along with other medications for some types of non-small-cell …

Mar 26, 2024 · Nintedanib information from Drugs.com, includes Nintedanib side effects, dosage, interactions, indications, how to take, and use in pregnancy and breastfeeding.

Jan 1, 2026 · Nintedanib is used to treat idiopathic pulmonary fibrosis. It helps prevent changes to the lung tissue. It is also used to treat people with a chronic (long-lasting) interstitial lung disease in …

Keep moving forward with OFEV® (nintedanib) capsules, the only twice-daily prescription medication approved to: treat adults with a lung disease called idiopathic pulmonary fibrosis (IPF).

Nintedanib is used to treat idiopathic pulmonary fibrosis (IPF; scarring of the lungs with an unknown cause). It is also used to treat certain types of chronic fibrosing interstitial lung diseases (ILD; an …

Nintedanib is an oral medication approved for the treatment of idiopathic pulmonary fibrosis, systemic sclerosis associated (also called scleroderma-associated) interstitial lung disease (SSc-ILD), and …

Nov 12, 2024 · Find patient medical information for Ofev (nintedanib) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

NINTEDANIB (nin TED a nib) treats conditions that cause the lungs to scar and stiffen, making it hard to breathe. It works by preventing changes to the lung tissue.

Aug 17, 2024 · Nintedanib is a small molecule tyrosine kinase inhibitor that binds to growth factor receptors, inhibiting the proliferation of fibroblasts. This action reduces ongoing fibrotic processes …

Nintedanib is a triple angiokinase inhibitor indicated for the treatment of idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and in combination with docetaxel for non …